BackSignify Health Overview

Signify Health Receivables

Latest receivables for SGFY: $180M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$183.00M
15.75% YoYΔ $-34.20M vs prior year quarter

Peer average

Loading

Signify Health Receivables History

Loading

Signify Health vs. peers: Receivables Comparison

Loading

Signify Health Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Signify Health (SGFY) FAQ

Signify Health's receivables stands at $180M as of December 2022. That compares with $220M in the prior-year period — down 15.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Signify Health reported $180M in receivables versus $220M a year earlier — a 15.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $220M in the prior-year period — down 15.7% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Signify Health's receivables evolved across reporting periods, while the comparison chart places SGFY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, receivables is commonly used to spot outliers. Signify Health's reading of $180M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.